A.   Administer a second dose.

B.   Continue to monitor consciousness for 2 minutes.

C.   Administer four doses at 15-second intervals.

D.   Provide another prescribed medication.

A.   Zolpidem

B.   Eszopiclone

C.   Ramelteon

D.   Zaleplon

A.   Deep sleep

B.   Dozing

C.   Sleepwalking

D.   Relaxation

A.   Daytime fatigue

B.   Vivid dreams

C.   Sleepwalking

D.   Bedwetting

A.   Short-acting barbiturates

B.   Long-acting barbiturates

C.   Ultra-short-acting barbiturates

D.   Intermediate-acting barbiturates

A.   Cardiac disease

B.   Drug allergy

C.   Narrow-angle glaucoma

D.   Epileptic disease

A.   Prevention of lightheadedness

B.   Reduction of muscle rigidity

C.   Reduction of choreiform movement

D.   Relief of nerve pain

A.   Increased perspiration

B.   Increased body weight

C.   Bedwetting

D.   Sleepwalking

A.   Alprazolam

B.   Midazolam

C.   Eszopiclone

D.   Ramelteon

A.   Diazepam

B.   Baclofen

C.   Dantrolene

D.   Cyclobenzaprine

A.   Decreased heart rate

B.   Dry mouth

C.   Constipation

D.   Amnesia

A.   Olanzapine

B.   Flumazenil

C.   Rifampin

D.   Verapamil

A.   The drug acts on gamma-aminobutyric acid (GABA) receptors in the central nervous system (CNS).

B.   The drug acts on benzodiazepine receptors that play a role in alcohol addiction.

C.   The drug may reduce the memory of painful symptoms related to alcohol withdrawal.

D.   The patient may need to be sedated to relieve symptoms of alcohol withdrawal.

A.   Sulfamethoxazole

B.   Ceftriaxone

C.   Phenobarbital

D.   Oxytocin

A.   Butabarbital

B.   Pentobarbital

C.   Mephobarbital

D.   Phenobarbital

A.   Decreased benzodiazepine effects

B.   Increased daytime sleepiness

C.   Prolonged benzodiazepine action

D.   Increased central nervous system (CNS) depression

A.   Flumazenil

B.   Olanzapine

C.   Activated charcoal

D.   Furosemide

A.   Presence of benzodiazepine receptors adjacent to the receptors responsible for alcohol addiction

B.   Inhibition of nerve impulse transmission

C.   Suppression of gamma-aminobutyric acid (GABA) receptors

D.   Amnesic properties

A.   Recommending that the patient consume a glass of warm lactose-free milk at bedtime

B.   Teaching the patient about meditation

C.   Instructing the patient to take low doses of benzodiazepines

D.   Encouraging the patient to maintain a well-balanced diet

A.   Flumazenil at a maximum dose of 1 mg

B.   Flumazenil at a maximum dose of 3 mg

C.   Phenylephrine at a maximum dose of 2 mg

D.   Phenylephrine at a maximum dose of 5 mg

A.   The patient is experiencing a barbiturate overdose.

B.   The patient is experiencing a muscle-relaxant overdose.

C.   The patient is experiencing benzodiazepine toxicity.

D.   The patient was administered azole along with benzodiazepine.

A.   Pentobarbital

B.   Ramelteon

C.   Zaleplon

D.   Diazepam

A.   Avoiding alcohol at bedtime

B.   Avoiding tobacco at bedtime

C.   Sleeping more during the day

D.   Establishing a set sleep pattern

A.   Diazepam

B.   Flurazepam

C.   Temazepam

D.   Midazolam

A.   Ataxia

B.   Dyspnea

C.   Hallucinations

D.   Alertness

A.   Naloxone

B.   Ipecac syrup

C.   Activated charcoal

D.   Flumazenil

A.   Dose of the drug used to produce the effect on the CNS

B.   Degree of inhibition of nerve impulse transmission to the CNS

C.   Degree of patient responsiveness to the drug given

D.   Duration of action on the central nervous system (CNS)

A.   Temazepam induces sleep in approximately 1 hour.

B.   Temazepam may cause gastrointestinal upset.

C.   The therapeutic activity of temazepam is reduced with sleep.

D.   Temazepam causes early awakening after sleep.

A.   Intravenous infiltration

B.   Infusion without dilution

C.   Infusion of other drugs

D.   Infusion that is too rapid

A.   Take lower doses of benzodiazepines.

B.   Use home remedies of vegetables and herbs.

C.   Drink lactose-free milk at bedtime.

D.   Go to acupuncture therapy.

A.   Diazepam, Midazolam, Eszopiclone

B.   Diazepam, Ramelteon, Midazolam

C.   Zolpidem, Diazepam, Midazolam

D.   Zolpidem, Ramelteon, Eszopiclone

A.   Administration of furosemide

B.   Administration of intravenous fluids

C.   Administration of activated charcoal

D.   Maintenance of an adequate airway

A.   "I should avoid exercise just before going to bed."

B.   "I will stop drinking coffee at least 6 hours before bedtime."

C.   "I will have a glass of warm milk before bed."

D.   "I may be prescribed benzodiazepines to promote sleep."

A.   Request a prescription to increase the dosage of pentobarbital.

B.   Instruct the patient to increase the dosage of the contraceptive drug.

C.   Suggest an alternate contraceptive method to the patient.

D.   Recommend discussing an alternative drug for seizures with the primary health care provider.

A.   Malignant hyperthermia

B.   Respiratory arrest

C.   Delirium tremens

D.   Tonic-clonic seizure

A.   Use the lowest effective dosage.

B.   Take the drug 30 minutes before sleeping.

C.   Drink coffee or tea in the morning.

D.   Avoid using this drug to induce sleep.

A.   Impairs coordinated movements

B.   Produces drowsiness, lethargy, and blurred vision

C.   Causes gastrointestinal distress

D.   Increases pain associated with activities

A.   Pentobarbital

B.   Thiopental

C.   Butabarbital

D.   Phenobarbital

A.   Hypotension, Drug allergy, Status epilepticus

B.   Pregnancy, Drug allergy, Significant respiratory difficulties

C.   Significant respiratory difficulties, Hypotension, Status epilepticus

D.   Hypotension, Status epilepticus, Pregnancy

A.   "Expect and prepare for a daytime hangover."

B.   "Take the medication with food or milk."

C.   "Allow at least 8 hours for sleep."

D.   "Report palpitations to the primary health care provider."

A.   Takes rifampin along with diazepam

B.   Takes olanzapine along with diazepam

C.   Drinks grapefruit juice along with diazepam

D.   Takes phenobarbital along with diazepam

A.   Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI), Atypical antidepressants

B.   Selective serotonin reuptake inhibitor (SSRI), Tricyclic antidepressant, Serotonin-norepinephrine reuptake inhibitor (SNRI)

C.   Tricyclic antidepressant, Monoamine oxidase inhibitor (MAOI), Atypical antidepressants

D.   Monoamine oxidase inhibitor (MAOI), Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI)

A.   Liver dysfunction

B.   Bronchial asthma

C.   Kidney dysfunction

D.   Narrow-angle glaucoma

A.   Eszopiclone

B.   Temazepam

C.   Alprazolam

D.   Clonazepam

A.   Baclofen

B.   Diazepam

C.   Zaleplon

D.   Pentobarbital

A.   Monitoring the patient’s renal and hepatic function

B.   Monitoring for suicidal tendencies

C.   Assessing the patient’s risk for injury or falls

D.   Encouraging the patient to drink more fluids

A.   Antidote preparation

B.   Seizure precautions

C.   Airway maintenance

D.   Comfort measures

A.   Level of consciousness

B.   Indicators of infection

C.   Amount of bleeding

D.   Muscle spasms

A.   0.2 mg (2 mL) of flumazenil was given intravenously (IV).

B.   A high dose of flumazenil was given.

C.   Alcohol was consumed with the benzodiazepines.

D.   The half-life of flumazenil is short.

A.   Ramelteon

B.   Eszopiclone

C.   Alprazolam

D.   Zaleplon

A.   "Nowadays I sleep for long hours."

B.   "I often feel dizzy and lightheaded."

C.   "I sleep less than I used to."

D.   "I feel like I breathe too deeply."

A.   0.5 mg (5 mL) IV over 30 seconds

B.   0.2 mg (2 mL) IV over 15 seconds

C.   0.2 mg (2 mL) intravenously (IV) over 30 seconds

D.   0.2 mg (2 mL) IV over 60 seconds